Skip to content

A study to assess safety and efficacy of SOT201 in patients with advance/metastatic cancer

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504330-21-00
Acronym
SC201 (VICTORIA-01)
Enrollment
32
Registered
2024-04-17
Start date
2024-07-22
Completion date
Unknown
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced/metastatic solid tumors

Interventions

None listed

Sponsors

SOTIO Biotech AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, Czechia, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026